Posted inCompany News Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant by TJ Halvorson May 20, 2025January 23, 2026
Posted inCompany News Carl Vause Is Hyalex Orthopaedics’ New CEO by Kim DelMonico February 4, 2022November 1, 2024
Posted inCompany News Mark Roby, Ph.D. New VP of R&D at Hyalex Orthopaedics by Elizabeth Hofheinz, M.P.H., M.Ed. December 5, 2019November 1, 2024
Posted inCompany News Hyalex Orthopaedics Raises $33 Million by Elizabeth Hofheinz, M.P.H., M.Ed. April 19, 2019November 1, 2024